Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy

Affiliations

• ¹ St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia.
• ² Winship Cancer Institute, Emory University, Atlanta, GA, USA.
• ³ Nizhniy Novgorod Region Clinical Hospital, Nizniy Novgorod, Russia.
• ⁴ Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
• ⁵ Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
• ⁶ Hôpital Claude Huriez, Lille, France.
• ⁷ Alfred Health-Monash University, Melbourne, Australia.
• ⁸ Atrium Health, Charlotte, NC, USA.
• ⁹ Silesian Medical University, Katowice, Poland.
• ¹⁰ Japanese Red Cross Medical Center, Tokyo, Japan.
• ¹¹ General Hospital Evangelismos, Athens, Greece.
• ¹² University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ¹³ Amgen, Inc., Thousand Oaks, CA, USA.
• ¹⁴ University Hospital Salamanca/IBSAL, Salamanca, Spain.